LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 76

Search options

  1. Article ; Online: Aging with multiple sclerosis: Clinical characterization of an elderly population, a cross-sectional study.

    Michelis, Daniele / Brunetti, Nicole / Solaro, Claudio / Mancardi, Giovanni Luigi / Uccelli, Antonio / Inglese, Matilde / Laroni, Alice

    Multiple sclerosis and related disorders

    2022  Volume 69, Page(s) 104464

    MeSH term(s) Humans ; Aged ; Multiple Sclerosis/diagnosis ; Multiple Sclerosis/epidemiology ; Cross-Sectional Studies ; Aging
    Language English
    Publishing date 2022-12-09
    Publishing country Netherlands
    Document type Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 2645330-7
    ISSN 2211-0356 ; 2211-0348
    ISSN (online) 2211-0356
    ISSN 2211-0348
    DOI 10.1016/j.msard.2022.104464
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Surgical treatment in Takayasu's arteritis with patch reconstruction of the left anterior descending coronary artery.

    Barbato, Luciano / Grasso, Maria Antonietta / Inglese, Luigi / Spagnolo, Salvatore

    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery

    2018  Volume 53, Issue 5, Page(s) 1097

    MeSH term(s) Coronary Vessels/diagnostic imaging ; Coronary Vessels/surgery ; Humans ; Reconstructive Surgical Procedures/methods ; Takayasu Arteritis/diagnostic imaging ; Takayasu Arteritis/surgery
    Language English
    Publishing date 2018-01-08
    Publishing country Germany
    Document type Case Reports ; Journal Article
    ZDB-ID 639293-3
    ISSN 1873-734X ; 1010-7940 ; 1567-4258
    ISSN (online) 1873-734X
    ISSN 1010-7940 ; 1567-4258
    DOI 10.1093/ejcts/ezx454
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Multisocieties position paper: Microbiological surveillance on flexible endoscopes.

    Casini, Beatrice / Pan, Angelo / Guarini, Alessandra / Rivara, Cinzia / Zullo, Angelo / Monica, Fabio / Cimbro, Monica / Casarano, Salvatore / Inglese, Agostino / Vaghi, Adriano / Schiffino, Luigi / Capezzuto, Erminio / Da Massa Carrara, Paola / Pasquale, Luigi

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

    2021  Volume 53, Issue 9, Page(s) 1105–1111

    Abstract: Transmission with endoscopes, particularly duodenoscope, of potential lethal infections prompted different scientific societies to deliver recommendations aimed reducing this risk. Some International societies extended recommendations on microbial ... ...

    Abstract Transmission with endoscopes, particularly duodenoscope, of potential lethal infections prompted different scientific societies to deliver recommendations aimed reducing this risk. Some International societies extended recommendations on microbial surveillance to all the endoscopes and devices used in the reprocessing procedure. Considering the relevance of the topic, 8 Italian scientific societies of physicians, nurses and technical operators prepared a concerted document taking into account Institutional advisories and facilities in Italy. The rules for a correct microbial surveillance on endoscopes were detailed in term of what, how and when to perform the procedure, also suggesting behaviors in case of contamination.
    MeSH term(s) Cross Infection/prevention & control ; Cross Infection/transmission ; Endoscopes, Gastrointestinal/adverse effects ; Endoscopes, Gastrointestinal/microbiology ; Equipment Contamination/prevention & control ; Humans ; Safety Management/standards
    Language English
    Publishing date 2021-07-13
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1459373-7
    ISSN 1878-3562 ; 1125-8055
    ISSN (online) 1878-3562
    ISSN 1125-8055
    DOI 10.1016/j.dld.2021.06.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Position Sense Deficits at the Lower Limbs in Early Multiple Sclerosis: Clinical and Neural Correlates.

    Iandolo, Riccardo / Bommarito, Giulia / Falcitano, Laura / Schiavi, Simona / Piaggio, Niccolò / Mancardi, Giovanni Luigi / Casadio, Maura / Inglese, Matilde

    Neurorehabilitation and neural repair

    2020  Volume 34, Issue 3, Page(s) 260–270

    Abstract: Background/ ... ...

    Abstract Background/Objective
    MeSH term(s) Adult ; Cerebral Cortex/diagnostic imaging ; Cerebral Cortex/physiopathology ; Corpus Callosum/diagnostic imaging ; Corpus Callosum/pathology ; Diffusion Tensor Imaging ; Female ; Humans ; Lower Extremity/physiopathology ; Magnetic Resonance Imaging ; Male ; Multiple Sclerosis, Relapsing-Remitting/complications ; Multiple Sclerosis, Relapsing-Remitting/diagnostic imaging ; Multiple Sclerosis, Relapsing-Remitting/pathology ; Multiple Sclerosis, Relapsing-Remitting/physiopathology ; Neuronal Plasticity/physiology ; Postural Balance/physiology ; Proprioception/physiology ; Prospective Studies ; Psychomotor Performance/physiology ; Sensation Disorders/etiology ; Sensation Disorders/physiopathology
    Language English
    Publishing date 2020-02-07
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1491637-x
    ISSN 1552-6844 ; 1545-9683 ; 0888-4390
    ISSN (online) 1552-6844
    ISSN 1545-9683 ; 0888-4390
    DOI 10.1177/1545968320902126
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Obesity and Dysmetabolic Factors among Deceased COVID-19 Adults under 65 Years of Age in Italy: A Retrospective Case-Control Study.

    Kondili, Loreta A / Quaranta, Maria Giovanna / Viganò, Mauro / Tata, Xhimi / D'Angelo, Franca / Lo Noce, Cinzia / Palmieri, Luigi / Onder, Graziano / D'Amico, Federico / Inglese, Elvira / Puoti, Massimo / Aghemo, Alessio / Tosti, Maria Elena

    Viruses

    2022  Volume 14, Issue 9

    Abstract: Background: Italy has witnessed high levels of COVID-19 deaths, mainly at the elderly age. We assessed the comorbidity and the biochemical profiles of consecutive patients ≤65 years of age to identify a potential risk profile for death.: Methods: We ... ...

    Abstract Background: Italy has witnessed high levels of COVID-19 deaths, mainly at the elderly age. We assessed the comorbidity and the biochemical profiles of consecutive patients ≤65 years of age to identify a potential risk profile for death.
    Methods: We retrospectively analyzed clinical data from consecutive hospitalized-for-COVID-19 patients ≤65 years, who were died (593 patients) or discharged (912 patients) during February-December 2020. Multivariate logistic regression identified the mortality risk factors.
    Results: Overweight (adjusted odds ratio (adjOR) 5.53, 95% CI 2.07-14.76), obesity (adjOR 8.58, CI 3.30-22.29), dyslipidemia (adjOR 10.02, 95% CI 1.06-94.22), heart disease (adjOR 17.68, 95% CI 3.80-82.18), cancer (adjOR 13.28, 95% CI 4.25-41.51) and male sex (adjOR 5.24, 95% CI 2.30-11.94) were associated with death risk in the youngest population. In the older population (46-65 years of age), the overweight and obesity were also associated with the death risk, however at a lower extent: the adjORs varyied from 1.49 to 2.36 for overweight patients and from 3.00 to 4.07 for obese patients. Diabetes was independently associated with death only in these older patients.
    Conclusion: Overweight, obesity and dyslipidemia had a pivotal role in increasing young individuals' death risk. Their presence should be carefully evaluated for prevention and/or prompt management of SARS-CoV2 infection in such high-risk patients to avoid the worst outcomes.
    MeSH term(s) Adult ; Age Factors ; Aged ; COVID-19/epidemiology ; Case-Control Studies ; Dyslipidemias/epidemiology ; Humans ; Italy/epidemiology ; Male ; Obesity/complications ; Obesity/epidemiology ; Overweight/complications ; Overweight/epidemiology ; RNA, Viral ; Retrospective Studies ; Risk Factors ; SARS-CoV-2
    Chemical Substances RNA, Viral
    Language English
    Publishing date 2022-09-07
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2516098-9
    ISSN 1999-4915 ; 1999-4915
    ISSN (online) 1999-4915
    ISSN 1999-4915
    DOI 10.3390/v14091981
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Investigating Gait, Movement, and Coordination in Children with Neurodevelopmental Disorders: Is There a Role for Motor Abnormalities in Atypical Neurodevelopment?

    Colizzi, Marco / Ciceri, Marco Luigi / Di Gennaro, Gianfranco / Morari, Beatrice / Inglese, Alessandra / Gandolfi, Marialuisa / Smania, Nicola / Zoccante, Leonardo

    Brain sciences

    2020  Volume 10, Issue 9

    Abstract: Motor abnormalities have been suggested to play a role in most neuropsychiatric disorders, as a potential generic neurodevelopmental vulnerability. However, they still represent a neglected area, with a paucity of empirical studies, especially in ... ...

    Abstract Motor abnormalities have been suggested to play a role in most neuropsychiatric disorders, as a potential generic neurodevelopmental vulnerability. However, they still represent a neglected area, with a paucity of empirical studies, especially in pediatric populations. This case-control study aimed to comprehensively assess motor functioning in children with atypical neurodevelopment and investigate whether any socio-demographic or clinical characteristics would concur with motor difficulties to distinguish children with neurodevelopmental disorders (NDD) from healthy controls. Socio-demographic (age and gender) and clinical (intelligence quotient, gait, movement, and coordination) data were collected on 114 children aged 5-15 (83 with NDD, 31 healthy controls). Male children were at significantly higher risk for NDD (OR: 13.023,
    Language English
    Publishing date 2020-09-02
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2651993-8
    ISSN 2076-3425
    ISSN 2076-3425
    DOI 10.3390/brainsci10090601
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?

    Schiavetti, Irene / Inglese, Matilde / Frau, Jessica / Signoriello, Elisabetta / Caleri, Francesca / Stromillo, Maria Laura / Ferrò, Maria Teresa / Rilla, Maria Teresa / Gandoglia, Ilaria / Gazzola, Paola / Brichetto, Giampaolo / Pasquali, Livia / Grimaldi, Luigi / Ulivelli, Monica / Marinelli, Fabiana / Cordera, Susanna / Clerico, Marinella / Conte, Antonella / Salvetti, Marco /
    Battaglia, Mario Alberto / Franciotta, Diego / Uccelli, Antonio / Sormani, Maria Pia

    European journal of neurology

    2023  Volume 30, Issue 8, Page(s) 2357–2364

    Abstract: Background and purpose: Although two doses of COVID-19 vaccine elicited a protective humoral response in most persons with multiple sclerosis (pwMS), a significant group of them treated with immunosuppressive disease-modifying therapies (DMTs) showed ... ...

    Abstract Background and purpose: Although two doses of COVID-19 vaccine elicited a protective humoral response in most persons with multiple sclerosis (pwMS), a significant group of them treated with immunosuppressive disease-modifying therapies (DMTs) showed less efficient responses.
    Methods: This prospective multicenter observational study evaluates differences in immune response after a third vaccine dose in pwMS.
    Results: Four hundred seventy-three pwMS were analyzed. Compared to untreated patients, there was a 50-fold decrease (95% confidence interval [CI] = 14.3-100.0, p < 0.001) in serum SARS-CoV-2 antibody levels in those on rituximab, a 20-fold decrease (95% CI = 8.3-50.0, p < 0.001) in those on ocrelizumab, and a 2.3-fold decrease (95% CI = 1.2-4.6, p = 0.015) in those on fingolimod. As compared to the antibody levels after the second vaccine dose, patients on the anti-CD20 drugs rituximab and ocrelizumab showed a 2.3-fold lower gain (95% CI = 1.4-3.8, p = 0.001), whereas those on fingolimod showed a 1.7-fold higher gain (95% CI = 1.1-2.7, p = 0.012), compared to patients treated with other DMTs.
    Conclusions: All pwMS increased their serum SARS-CoV-2 antibody levels after the third vaccine dose. The mean antibody values of patients treated with ocrelizumab/rituximab remained well below the empirical "protective threshold" for risk of infection identified in the CovaXiMS study (>659 binding antibody units/mL), whereas for patients treated with fingolimod this value was significantly closer to the cutoff.
    MeSH term(s) Humans ; COVID-19 Vaccines ; Antibody Formation ; Fingolimod Hydrochloride ; Multiple Sclerosis/drug therapy ; Prospective Studies ; Rituximab/therapeutic use ; COVID-19/prevention & control ; SARS-CoV-2 ; Antibodies, Viral ; Vaccination
    Chemical Substances COVID-19 Vaccines ; Fingolimod Hydrochloride (G926EC510T) ; Rituximab (4F4X42SYQ6) ; Antibodies, Viral
    Language English
    Publishing date 2023-05-28
    Publishing country England
    Document type Observational Study ; Multicenter Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1280785-0
    ISSN 1468-1331 ; 1351-5101 ; 1471-0552
    ISSN (online) 1468-1331
    ISSN 1351-5101 ; 1471-0552
    DOI 10.1111/ene.15830
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Impact of Natural Killer (NK) Cells on Immune Reconstitution, and Their Potential as a Biomarker of Disease Activity, in Alemtuzumab-Treated Patients with Relapsing Remitting Multiple Sclerosis: An Observational Study.

    Palmeri, Serena / Ponzano, Marta / Ivaldi, Federico / Signori, Alessio / Lapucci, Caterina / Casella, Valentina / Ferrò, Maria Teresa / Vigo, Tiziana / Inglese, Matilde / Mancardi, Giovanni Luigi / Uccelli, Antonio / Laroni, Alice

    CNS drugs

    2021  Volume 36, Issue 1, Page(s) 83–96

    Abstract: Background: Defining immune mechanisms leading to multiple sclerosis (MS) is difficult, due to the great inter-individual difference in immune system responses. The anti-CD52 antibody alemtuzumab transiently abolishes differences in immune parameters ... ...

    Abstract Background: Defining immune mechanisms leading to multiple sclerosis (MS) is difficult, due to the great inter-individual difference in immune system responses. The anti-CD52 antibody alemtuzumab transiently abolishes differences in immune parameters among individuals, allowing analysis of subsequent immune cell repopulation patterns, and their possible role in MS.
    Objective: To evaluate the correlation between innate and adaptive immune cell subsets and disease activity in MS in the context of treatment with alemtuzumab.
    Methods: A two-center observational cohort of patients treated with alemtuzumab underwent immune profiling of T, B, and natural killer (NK) cells, biomarker, clinical and radiological follow-up.
    Results: After treatment, the percentage of NK and B cells increased; NK, T- and B-cell populations underwent a profound rearrangement. Within the effector T-cell compartment, treatment led to a transient decrease, followed by an increase, of T-helper 1 cells, and to a transient decrease of T-helper 17 cells. Within the T-regulatory compartment, naïve T-regulatory cells increased. Within the B-cell compartment, memory B cells and mature B cells decreased, whereas transitional B cells increased. Within the NK cell compartment, CD56
    Conclusions: The results of this study provide novel evidence that NK cells influence reconstitution of adaptive immune cells upon alemtuzumab and that patients with a successful response to alemtuzumab have an early immune reconstitution dominated by NK cells.
    MeSH term(s) Adult ; Alemtuzumab/therapeutic use ; Antineoplastic Agents, Immunological/therapeutic use ; Biomarkers/blood ; Female ; Humans ; Italy ; Killer Cells, Natural/immunology ; Longitudinal Studies ; Male ; Multiple Sclerosis, Relapsing-Remitting/drug therapy ; Multiple Sclerosis, Relapsing-Remitting/immunology
    Chemical Substances Antineoplastic Agents, Immunological ; Biomarkers ; Alemtuzumab (3A189DH42V)
    Language English
    Publishing date 2021-12-11
    Publishing country New Zealand
    Document type Journal Article ; Multicenter Study ; Observational Study ; Research Support, Non-U.S. Gov't
    ZDB-ID 1203800-3
    ISSN 1179-1934 ; 1172-7047
    ISSN (online) 1179-1934
    ISSN 1172-7047
    DOI 10.1007/s40263-021-00875-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Strategie riperfusive nell'infarto miocardico acuto: cosa dicono i trial.

    Inglese, Luigi / Fantoni, Cecilia

    Giornale italiano di cardiologia (2006)

    2010  Volume 11, Issue 10 Suppl 1, Page(s) 57S–60S

    Abstract: The efficacy of reperfusion therapy, both pharmacological and mechanical, in patients with ST-elevation myocardial infarction (STEMI) is time-dependent. The relation is closer the earlier we are from symptom onset and is valid for thrombolysis within 6h ... ...

    Title translation ST-elevation myocardial infarction: reperfusion strategy based on the results from large clinical trials.
    Abstract The efficacy of reperfusion therapy, both pharmacological and mechanical, in patients with ST-elevation myocardial infarction (STEMI) is time-dependent. The relation is closer the earlier we are from symptom onset and is valid for thrombolysis within 6h and for primary angioplasty till to at least the twelfth hour. Benefits of reperfusion bring to an advantage both in terms of myocardial salvage and left ventricular systolic function and in terms of quality of life and long-term survival. Although mortality and morbidity of STEMI patients have been greatly reduced in the last 20 years, the need for guideline revision and implementation remains urgent, mostly because mortality of real-world STEMI patients keeps to be always much higher compared to what reported in big randomized controlled trials. The most important indications from big trials and guidelines regarding both pharmacological and non-pharmacological reperfusion strategy in STEMI patients are discussed.
    MeSH term(s) Angioplasty, Balloon, Coronary ; Anticoagulants/administration & dosage ; Anticoagulants/therapeutic use ; Fibrinolytic Agents/administration & dosage ; Fibrinolytic Agents/therapeutic use ; Guidelines as Topic ; Heparin/administration & dosage ; Heparin/therapeutic use ; Humans ; Meta-Analysis as Topic ; Myocardial Infarction/drug therapy ; Myocardial Infarction/mortality ; Myocardial Infarction/therapy ; Platelet Aggregation Inhibitors/administration & dosage ; Platelet Aggregation Inhibitors/therapeutic use ; Pyridines/administration & dosage ; Pyridines/therapeutic use ; Quality of Life ; Randomized Controlled Trials as Topic ; Thrombolytic Therapy ; Ticlopidine/administration & dosage ; Ticlopidine/analogs & derivatives ; Ticlopidine/therapeutic use ; Time Factors
    Chemical Substances Anticoagulants ; Fibrinolytic Agents ; Platelet Aggregation Inhibitors ; Pyridines ; thienopyridine ; Heparin (9005-49-6) ; clopidogrel (A74586SNO7) ; Ticlopidine (OM90ZUW7M1)
    Language Italian
    Publishing date 2010-10
    Publishing country Italy
    Document type English Abstract ; Journal Article ; Review
    ZDB-ID 2272414-X
    ISSN 1972-6481 ; 1827-6806
    ISSN (online) 1972-6481
    ISSN 1827-6806
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Carbon dioxide (CO

    De Angelis, Chiara / Sardanelli, Francesco / Perego, Matteo / Alì, Marco / Casilli, Francesco / Inglese, Luigi / Mauri, Giovanni

    The international journal of cardiovascular imaging

    2017  Volume 33, Issue 11, Page(s) 1655–1662

    Abstract: To assess feasibility, efficacy and safety of carbon dioxide ( ... ...

    Abstract To assess feasibility, efficacy and safety of carbon dioxide (CO
    Language English
    Publishing date 2017-11
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2055311-0
    ISSN 1875-8312 ; 1573-0743 ; 1569-5794 ; 0167-9899
    ISSN (online) 1875-8312 ; 1573-0743
    ISSN 1569-5794 ; 0167-9899
    DOI 10.1007/s10554-017-1175-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top